kesimpta
Generic: ofatumumab
Labeler: novartis pharmaceuticals corporationDrug Facts
Product Profile
Brand Name
kesimpta
Generic Name
ofatumumab
Labeler
novartis pharmaceuticals corporation
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ofatumumab 20 mg/.4mL
Manufacturer
Identifiers & Regulatory
Product NDC
0078-1007
Product ID
0078-1007_2a949531-807f-4e6e-9ac0-68943e6c6685
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA125326
Listing Expiration
2026-12-31
Marketing Start
2009-10-26
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00781007
Hyphenated Format
0078-1007
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
kesimpta (source: ndc)
Generic Name
ofatumumab (source: ndc)
Application Number
BLA125326 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/.4mL
Packaging
- 1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS
- 1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "2a949531-807f-4e6e-9ac0-68943e6c6685", "openfda": {"nui": ["N0000175657", "N0000175078"], "unii": ["M95KG522R0"], "rxcui": ["2390949", "2390954"], "spl_set_id": ["6a8a3f53-2062-48ff-9dbe-b939df133ca3"], "pharm_class_epc": ["CD20-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["CD20-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS", "package_ndc": "0078-1007-68", "marketing_start_date": "20200820"}, {"sample": true, "description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS", "package_ndc": "0078-1007-98", "marketing_start_date": "20200820"}], "brand_name": "KESIMPTA", "product_id": "0078-1007_2a949531-807f-4e6e-9ac0-68943e6c6685", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["CD20-directed Antibody Interactions [MoA]", "CD20-directed Cytolytic Antibody [EPC]"], "product_ndc": "0078-1007", "generic_name": "ofatumumab", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "KESIMPTA", "active_ingredients": [{"name": "OFATUMUMAB", "strength": "20 mg/.4mL"}], "application_number": "BLA125326", "marketing_category": "BLA", "marketing_start_date": "20091026", "listing_expiration_date": "20261231"}